share_log

HC Wainwright & Co. Reiterates Buy on Viking Therapeutics, Maintains $90 Price Target

Benzinga ·  Apr 25 07:19

HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $90 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment